Please ensure Javascript is enabled for purposes of website accessibility
Search
▲ S&P 500 +---% | ▲ Stock Advisor +---%
Accessibility Log In Help
Accessibility Menu
Arrow-Thin-Down
S&P 500
5,980.87
-0.0%
-$1.85
Arrow-Thin-Down
DJI
42,171.66
-0.1%
-$44.14
Arrow-Thin-Down
NASDAQ
19,546.27
+0.1%
+$25.18
Arrow-Thin-Down
Bitcoin
104,806.00
+0.2%
+229.88
Arrow-Thin-Down
AAPL
$196.67
+0.5%
+$1.03
Arrow-Thin-Down
AMZN
$212.81
-0.9%
-$2.01
Arrow-Thin-Down
GOOG
$174.14
-1.7%
-$3.08
Arrow-Thin-Down
META
$695.20
-0.3%
-$2.03
Arrow-Thin-Down
MSFT
$479.98
+0.4%
+$1.94
Arrow-Thin-Down
NVDA
$145.38
+0.9%
+$1.26
Arrow-Thin-Down
TSLA
$322.06
+1.8%
+$5.71
Daily Stock Gainers Daily Stock Losers Most Active Stocks
Dave Williamson

Dave Williamson

XMFGreenwave4

The Motley Fool's Healthcare Analyst, I specialize in Pharma, Biotech, and how the ACA (Obamacare) is changing the business of healthcare in America. Follow me on Twitter for breaking stock news, policy thoughts, and misc musings...

Recent Articles by Dave Williamson

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services